DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gemzar (Gemcitabine) - White Blood Cell Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with White Blood Cell Count Decreased (28)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Gemzar (Gemcitabine) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Gemzar side effects in male

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Off Label Use, White Blood Cell Count Decreased, Neoplasm Progression, Metastases To Bone, Nephrotic Syndrome, Acute Prerenal Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 750 mg, every 3 weeks
    Indication: Pleural Mesothelioma Malignant
    Start date: 2009-03-12
    End date: 2009-09-24

Gemzar
    Dosage: unk
    Start date: 2010-05-28
    End date: 2010-06-04

Other drugs received by patient: Amlodipine; Vitamin B12; Panvitan; Calblock; Amlodipine; Cisplatin



Possible Gemzar side effects in female

Reported by a physician from Japan on 2012-08-16

Patient: female, weighing 42.0 kg (92.4 pounds)

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Nausea, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
Gemzar
    Dosage: 1500 mg, other
    Indication: Gallbladder Cancer Stage IV
    Start date: 2011-07-25
    End date: 2011-08-29

Gemzar
    Dosage: 1300 mg, unk
    Start date: 2011-10-10
    End date: 2011-12-05

Other drugs received by patient: Cisplatin; Cisplatin



Possible Gemzar side effects in 74 year old female

Reported by a consumer/non-health professional from Japan on 2012-07-11

Patient: 74 year old female

Reactions: White Blood Cell Count Decreased, Nausea, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1300 mg, unk
    End date: 2011-12-05

Gemzar
    Dosage: 1500 mg, other
    Indication: Gallbladder Cancer Stage IV
    Start date: 2011-07-25
    End date: 2011-08-15

Other drugs received by patient: Cisplatin; Cisplatin



Possible Gemzar side effects in female

Reported by a physician from Japan on 2012-07-10

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Dermatitis Acneiform, Paronychia, White Blood Cell Count Decreased, Stomatitis, Alanine Aminotransferase Increased, Pyrexia, Diarrhoea, Interstitial Lung Disease, Aspartate Aminotransferase Increased, Platelet Count Decreased, Neutrophil Count Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1000 mg/m2, weekly
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-09-30
    End date: 2011-10-07

Gemzar
    Dosage: 1000 mg/m2, weekly
    Start date: 2011-11-14
    End date: 2011-11-28

Gemzar
    Dosage: 1000 mg/m2, weekly
    Start date: 2011-10-24
    End date: 2011-10-31

Tarceva
    Dosage: 100 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-09-30
    End date: 2011-12-09

Other drugs received by patient: Rabeprazole Sodium; Levofloxacin; Sennoside / 00571901 /; Rebamipide; Magmitt; Loxoprofen; Goodmin



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: White Blood Cell Count Decreased, Neoplasm Malignant, Immunosuppression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar

Other drugs received by patient: Carboplatin



Possible Gemzar side effects in female

Reported by a consumer/non-health professional from Japan on 2012-06-25

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: White Blood Cell Count Decreased, Colitis Ischaemic, Platelet Count Decreased, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1600 mg, other
    Indication: Gallbladder Cancer Stage IV
    Start date: 2012-03-06
    End date: 2012-03-13

Gemzar
    Dosage: 1000 mg, other
    Start date: 2012-05-24
    End date: 2012-05-24

Other drugs received by patient: Decadron / 00016002 /; Aloxi; Emend; Cisplatin; Cisplatin; Norvasc



Possible Gemzar side effects in male

Reported by a physician from Japan on 2012-04-11

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Pruritus Generalised, White Blood Cell Count Decreased, Interstitial Lung Disease, Cerebral Infarction, Dehydration

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1600 mg, other/day one, eight and 15
    Indication: Pancreatic Carcinoma Stage IV
    Start date: 2011-09-08
    End date: 2011-11-24

Gemzar
    Dosage: 1600 mg, other/ every other week
    Start date: 2011-12-08
    End date: 2011-12-22

Other drugs received by patient: TS 1



Possible Gemzar side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-11

Patient: 68 year old female

Reactions: White Blood Cell Count Decreased, Anaemia, Neutrophil Count Decreased, Disease Progression

Drug(s) suspected as cause:
Gemzar
    Indication: Ovarian Cancer

Hycamtin
    Dosage: 1.5mgm2 per day
    Indication: Ovarian Cancer
    Start date: 2011-09-05
    End date: 2011-12-17



Possible Gemzar side effects in male

Reported by a physician from Japan on 2012-03-30

Patient: male, weighing 60.4 kg (132.9 pounds)

Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Gemzar
    Dosage: unk
    Indication: Transitional Cell Carcinoma
    Start date: 2009-06-30
    End date: 2009-11-21

Gemzar
    Dosage: 1600 mg, unk
    Start date: 2010-01-08
    End date: 2010-02-18

Other drugs received by patient: Decadron; Daikentyuto; Paclitaxel; Lansoprazole; Granisetron; Zantac; Basen; Oxycontin; Restamin; Cisplatin; Clonazepam



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from Japan on 2012-03-14

Patient: male, weighing 60.4 kg (132.9 pounds)

Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Gemzar
    Dosage: 1600 mg, unk
    Start date: 2010-01-08
    End date: 2010-02-18

Gemzar
    Dosage: unk
    Indication: Transitional Cell Carcinoma
    Start date: 2009-06-30
    End date: 2009-11-21

Other drugs received by patient: Restamin; Daikentyuto; Cisplatin; Basen; Clonazepam; Paclitaxel; Decadron; Zantac; Granisetron; Lansoprazole; Oxycontin



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from Japan on 2012-03-13

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Pruritus Generalised, White Blood Cell Count Decreased, Cerebral Infarction, Interstitial Lung Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1600 mg, other/day one, eight and 15
    Indication: Pancreatic Carcinoma Stage IV
    Start date: 2011-09-08
    End date: 2011-11-24

Gemzar
    Dosage: 1600 mg, other/ every other week
    Start date: 2011-12-08
    End date: 2011-12-22

Other drugs received by patient: TS 1



Possible Gemzar side effects in 67 year old male

Reported by a consumer/non-health professional from Japan on 2012-03-08

Patient: 67 year old male

Reactions: White Blood Cell Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar

Zolpidem
    Administration route: Oral
    Indication: Insomnia
    Start date: 2012-01-28

Other drugs received by patient: Insulin; Lansoprazole



Possible Gemzar side effects in female

Reported by a physician from Japan on 2012-03-01

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: White Blood Cell Count Decreased, Nasopharyngitis, Rash, Oropharyngeal Pain, Diarrhoea, C-Reactive Protein Increased, Cholangitis, Insomnia

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 100 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-09-06

Gemzar
    Dosage: unk
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-07-19
    End date: 2011-08-23

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-06
    End date: 2011-10-06

Gemzar
    Dosage: 1000 mg/m2, uid/qd
    Start date: 2011-11-17
    End date: 2011-11-17

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-13
    End date: 2011-10-13

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2011-12-01
    End date: 2011-12-01

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2012-01-12
    End date: 2012-01-12

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-04
    End date: 2011-11-04

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2012-01-05
    End date: 2012-01-05

Gemzar
    Dosage: 600 mg/m2, uid/qd
    Start date: 2012-01-19

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-20
    End date: 2011-10-20

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-10
    End date: 2011-11-10

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2011-12-15
    End date: 2011-12-15

Gemzar
    Dosage: 1100 mg/m2, weekly x 3 wks
    Start date: 2011-09-06
    End date: 2011-09-20

Other drugs received by patient: Naproxen; Furosemide; Lexotan; Lexotan; Lansoprazole; Oxycontin; Trimebutine Maleate; Toughmac E; Primperan TAB; Urso 250; Miya BM



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from Japan on 2012-02-27

Patient: male, weighing 60.4 kg (132.9 pounds)

Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Gemzar
    Dosage: unk
    Indication: Transitional Cell Carcinoma
    Start date: 2009-06-30
    End date: 2009-11-21

Gemzar
    Dosage: 1600 mg, unk
    Start date: 2010-01-08
    End date: 2010-02-18

Other drugs received by patient: Cisplatin; Daikentyuto; Clonazepam; Paclitaxel; Basen; Granisetron; Lansoprazole; Restamin; Zantac; Oxycontin; Decadron



Possible Gemzar side effects in female

Reported by a physician from Japan on 2012-02-23

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: White Blood Cell Count Decreased, Nasopharyngitis, Rash, Oropharyngeal Pain, C-Reactive Protein Increased, Diarrhoea, Insomnia, Cholangitis

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 100 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-09-06

Gemzar
    Dosage: 1100 mg/m2, weekly x 3 wks
    Start date: 2011-09-06
    End date: 2011-09-20

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2011-12-15
    End date: 2011-12-15

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2012-01-12
    End date: 2012-01-12

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-10
    End date: 2011-11-10

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-04
    End date: 2011-11-04

Gemzar
    Dosage: 1000 mg/m2, uid/qd
    Start date: 2011-11-17
    End date: 2011-11-17

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2012-01-05
    End date: 2012-01-05

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-20
    End date: 2011-10-20

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-06
    End date: 2011-10-06

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-13
    End date: 2011-10-13

Gemzar
    Dosage: unk
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-07-19
    End date: 2011-08-23

Gemzar
    Dosage: 800 mg/m2, uid/qd
    Start date: 2011-12-01
    End date: 2011-12-01

Gemzar
    Dosage: 600 mg/m2, uid/qd
    Start date: 2012-01-19

Other drugs received by patient: Furosemide; Toughmac E; Primperan TAB; Urso 250; Oxycontin; Trimebutine Maleate; Lexotan; Miya BM; Naproxen; Lansoprazole; Lexotan



Possible Gemzar side effects in 67 year old male

Reported by a consumer/non-health professional from Japan on 2012-02-23

Patient: 67 year old male

Reactions: White Blood Cell Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar

Zolpidem
    Administration route: Oral
    Indication: Insomnia
    Start date: 2012-01-28

Other drugs received by patient: Lansoprazole; Insulin



Possible Gemzar side effects in male

Reported by a physician from Japan on 2012-02-20

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: White Blood Cell Count Decreased, Pruritus Generalised, Interstitial Lung Disease, Cerebral Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1600 mg, other/ every other week
    Start date: 2011-12-08
    End date: 2011-12-22

Gemzar
    Dosage: 1600 mg, other/day one, eight and 15
    Indication: Pancreatic Carcinoma Stage IV
    Start date: 2011-09-08
    End date: 2011-11-24

Other drugs received by patient: TS 1



Possible Gemzar side effects in 80 year old male

Reported by a physician from Japan on 2012-01-30

Patient: 80 year old male

Reactions: White Blood Cell Count Decreased, Pneumonia, Hepatic Atrophy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: unk
    Indication: Bile Duct Cancer Recurrent
    Start date: 2011-01-01

Gemzar
    Dosage: unk, 2/m
    End date: 2011-05-01



Possible Gemzar side effects in female

Reported by a physician from Japan on 2012-01-03

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Diarrhoea, Cholangitis, Rash

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 100 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-09-06

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-06
    End date: 2011-10-06

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-20
    End date: 2011-10-20

Gemzar
    Dosage: 1000 mg/m2, uid/qd
    Start date: 2011-11-17

Gemzar
    Dosage: 1100 mg/m2, weekly x 3 wks
    Start date: 2011-09-06
    End date: 2011-09-20

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-10-13
    End date: 2011-10-13

Gemzar
    Dosage: unk
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-07-19
    End date: 2011-08-23

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-04
    End date: 2011-11-04

Gemzar
    Dosage: 1100 mg/m2, uid/qd
    Start date: 2011-11-10
    End date: 2011-11-10

Other drugs received by patient: Furosemide; Urso 250; Toughmac E; Primperan TAB; Miya BM; Lexotan; Trimebutine Maleate; Lexotan; Naproxen; Oxycontin; Lansoprazole



Possible Gemzar side effects in female

Reported by a consumer/non-health professional from Japan on 2011-12-22

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: White Blood Cell Count Decreased, Hypersensitivity, Shock Haemorrhagic, Pleural Effusion, Haemolytic Uraemic Syndrome, Pleural Haemorrhage

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Gemzar
    Dosage: 1500 mg, other
    Indication: Ovarian Cancer Recurrent
    Start date: 2008-04-11
    End date: 2008-08-01

Gemzar
    Dosage: 1000 mg, other
    Start date: 2008-08-22
    End date: 2008-12-19

Other drugs received by patient: Carboplatin; Loxonin; Vasolax; Selbex; Acetaminophen; Primperan / 00041901 /



Possible Gemzar side effects in female

Reported by a physician from Japan on 2011-12-14

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Intestinal Obstruction, Erythropenia, Ovarian Cancer

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: cycle 6
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-10-13
    End date: 2009-10-13

Doxorubicin HCL
    Dosage: cycle 5
    Start date: 2009-09-02
    End date: 2009-09-02

Doxorubicin HCL
    Dosage: cycle 3
    Start date: 2009-06-26
    End date: 2009-06-26

Doxorubicin HCL
    Dosage: cycle 11
    Start date: 2010-03-01
    End date: 2010-03-01

Doxorubicin HCL
    Dosage: cycle 4
    Start date: 2009-08-05
    End date: 2009-08-05

Doxorubicin HCL
    Dosage: cycle 7
    Start date: 2009-11-01
    End date: 2009-11-01

Doxorubicin HCL
    Dosage: cycle 8
    Start date: 2009-12-01
    End date: 2009-12-01

Doxorubicin HCL
    Dosage: cycle 9
    Start date: 2010-01-01
    End date: 2010-01-01

Doxorubicin HCL
    Start date: 2009-04-28
    End date: 2009-04-28

Doxorubicin HCL
    Dosage: cycle 10
    Start date: 2010-02-01
    End date: 2010-02-01

Doxorubicin HCL
    Start date: 2009-05-27
    End date: 2009-05-27

Doxorubicin HCL
    Dosage: cycle 12
    Start date: 2010-03-01
    End date: 2010-03-01

Gemzar
    Indication: Ovarian Cancer Recurrent
    Start date: 2008-10-29
    End date: 2010-10-13

Oxaliplatin
    Indication: Ovarian Cancer Recurrent
    Start date: 2008-10-01
    End date: 2010-10-13

Other drugs received by patient: Neutrogin; TPN; Primperan TAB; Primperan TAB; Gasmotin; Motilium; TPN; Concentrated Human RED Blood Cells; Celecoxib; DAI-Kenchu-TO; Dacarbazine; Concentrated Human RED Blood Cells; Concentrated Human RED Blood Cells; Primperan TAB; Motilium; Pydoxal; TPN; Concentrated Human RED Blood Cells; Lansoprazole



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-01

Patient: male

Reactions: Weight Decreased, Haemoglobin Decreased, Dysgeusia, White Blood Cell Count Decreased, Diarrhoea, Alopecia, Rash, Constipation, Eating Disorder

Drug(s) suspected as cause:
Gemzar

Other drugs received by patient: Tarceva



Possible Gemzar side effects in male

Reported by a consumer/non-health professional from Japan on 2011-11-22

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: White Blood Cell Count Decreased, Off Label Use, Neoplasm Progression, Metastases To Bone, Acute Prerenal Failure, Nephrotic Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 750 mg, every 3 weeks
    Indication: Pleural Mesothelioma Malignant
    Start date: 2009-03-12
    End date: 2009-09-24

Gemzar
    Dosage: unk
    Start date: 2010-05-28
    End date: 2010-06-04

Other drugs received by patient: Calblock; Panvitan; Cisplatin; Methycobal; Amlodipine; Amlodipine



Possible Gemzar side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-17

Patient: female

Reactions: Weight Decreased, White Blood Cell Count Decreased, Aphagia, Oral Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1500 mg, other
    Start date: 2011-11-09

Gemzar
    Dosage: 2000 mg, other
    Indication: Breast Cancer Recurrent
    Start date: 2011-10-17

Other drugs received by patient: Taxotere; Taxotere; Percocet



Possible Gemzar side effects in 63 year old male

Reported by a consumer/non-health professional from United States on 2011-11-02

Patient: 63 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: White Blood Cell Count Decreased, Platelet Count Decreased, Gastroduodenal Ulcer

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose on 24mar2011-24mar11=1day interrupted on 13apr2011,resumed on 27apr11 with dose reduced
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-03-24

Gemzar
    Dosage: last dose on 01apr2011, dur: 9 days. interrupted on 13apr2011,resumed on 27apr11
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-03-24

Necitumumab
    Dosage: necitumumab liqiud 24mar2011-01apr2011(9 days) interrupted on 13apr2011,resumed on 27apr11
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-03-24

Other drugs received by patient: Bisoprolol; Permixon; Procodin; Simvastatin; Corticosteroid; Plavix; Ventolin



Possible Gemzar side effects in female

Reported by a physician from Japan on 2011-10-24

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Intestinal Obstruction, Erythropenia, Ovarian Cancer

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Start date: 2009-08-05
    End date: 2009-08-05

Doxorubicin HCL
    Start date: 2009-05-27
    End date: 2009-05-27

Doxorubicin HCL
    Start date: 2009-06-26
    End date: 2009-06-26

Doxorubicin HCL

Doxorubicin HCL
    Start date: 2009-09-02
    End date: 2009-09-02

Doxorubicin HCL
    Indication: Ovarian Cancer Recurrent

Doxorubicin HCL
    Start date: 2009-10-13
    End date: 2009-10-13

Doxorubicin HCL
    Start date: 2010-01-01
    End date: 2010-01-01

Doxorubicin HCL
    Start date: 2010-01-01
    End date: 2010-01-01

Doxorubicin HCL
    Start date: 2009-04-28
    End date: 2009-04-28

Gemzar
    Indication: Ovarian Cancer Recurrent
    Start date: 2008-10-29

Oxaliplatin
    Indication: Ovarian Cancer Recurrent
    Start date: 2008-10-01

Other drugs received by patient: Pydoxal; Primperan TAB; TPN; Celecoxib; Motilium; TPN; DAI-Kenchu-TO; Concentrated Human RED Blood Cells; Lansoprazole; Gasmotin; Motilium; Dacarbazine; TPN; Concentrated Human RED Blood Cells; Primperan TAB; Primperan TAB; Concentrated Human RED Blood Cells; Neutrogin; Concentrated Human RED Blood Cells



Possible Gemzar side effects in female

Reported by a physician from Japan on 2011-10-18

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Neutrophil Count Decreased, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-10-02

Doxorubicin HCL
    Dosage: cycle 4
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-11-20
    End date: 2009-11-20

Doxorubicin HCL
    Dosage: cycle 2
    Start date: 2009-08-21
    End date: 2009-08-21

Doxorubicin HCL
    Dosage: cycle 1
    Start date: 2009-07-24
    End date: 2009-07-24

Doxorubicin HCL
    Dosage: cycle 3
    Start date: 2009-09-18
    End date: 2009-09-18

Doxorubicin HCL
    Dosage: cycle 4
    Start date: 2009-10-19
    End date: 2009-10-19

Gemzar
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-06-12

Oxaliplatin
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-06-12
    End date: 2009-09-04

Other drugs received by patient: Cefazolin Sodium; Celecoxib; Herceptin; Neutrogin; Lansoprazole; Pydoxal; Unknown Medication; Itraconazole



Possible Gemzar side effects in male

Reported by a physician from Japan on 2011-10-14

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: White Blood Cell Count Decreased, Cancer Pain, Recall Phenomenon, Generalised Oedema, Renal Impairment, Diarrhoea, Platelet Count Decreased, Ureteric Cancer Recurrent, Neutropenia, Bronchiolitis, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemzar
    Dosage: 1300 mg, day 1, 8, 15
    Indication: Ureteric Cancer
    Start date: 2010-01-06
    End date: 2010-02-01

Gemzar
    Dosage: 1300 mg, day 1, 8, 15
    Start date: 2010-12-13
    End date: 2011-03-01

Other drugs received by patient: Cisplatin; Cisplatin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014